|
六、參考文獻 1. Portoghese, P. S. A New Concept on the Mode of Interaction of Narcotic Analgesics with Receptors. J. Med. Chem. 1965, 8, 609-616. 2. Gilbert, P. E.; Martin, W. R. The Effects of Morphine- and Nalorphine- Like Drugs in the Nondependent, Morphine-Dependent and Cycazocine-Dependent Chronic Spinal Dog. J. Pharmacol. Exp. Ther. 1976, 198, 66-82. 3. Martin, W. R.; Eades, C. G.; Thompson, J. A.; Huppler, R. E. The Effects of Morphine- and Nalorphine- Like Drugs in the Nondependent, Morphine-Dependent Chronic Spinal Dog. J. Pharmacol. Exp. Ther. 1976, 197, 517-532. 4. Brownstein, M. J. A Brief History of Opiates, Opioid Peptides, and Opioid Receptors. Proc. Natl. Acad. USA 1993, 90, 5391-5393. 5. Takemori, A. E.; Portoghese, P. S. Affinity Labels for Opioid Receptor. Ann. Rev. Pharmacol. Toxical. 1985, 25, 193-223. 6. Rice, K.C.; Jacobson, A. E.; Burke Jr, T. R.; Bajwa, B. S.; Streaty, R. A.; Klee, W. A. Irreversible Ligands with High Selectivity Toward or Opioid Receptors. Science 1983, 220, 314-316. 7. Burke Jr, T. R.; Bajwa, B. S.; Jacobson, A. E.; Rice, K. C.; Streaty, R. A.; Klee, W. A. Probes for Narcotic Receptor Mediated Phenomena. 7. Synthesis and Pharmacological Properties of Irreversible Ligands Specific for or opiate receptors. J. Med. Chem. 1984, 27, 1570-1574. 8. Portoghese, P. S.; Larson, D. L.; Sayre, L. M.; Fries, D. S.; Takemori, A. E. A Novel Opioid Receptor Site Directed Alkylating Agent with Irreversible Narcotic Antagonistic and Reversible Agonistic Activities. J. Med. Chem. 1980, 23, 233-234. 9. Klein, P.; Nelson, W. L.; Yao, Y. H.; Simon, E. J. Electrophilic -Methylene--lactone and Isothiocyanate Opioid Ligands Related to Etorphine. J. Med. Chem. 1990, 33, 2286-2296. 10. Derrick, I.; Moynihan, H. A.; Broadbear, J.; Woods, J. H.; Lewis, J.; W. 6N-Cinnamoyl--Naltrexamine and Its p-Nitro Derivative. High Efficacy -Opioid Agonists with Weak Antagonist Actions. Bioorg. Med. Chem. Lett. 1996, 6, 167-172. 11. Xu, J. Y.; Mozaffari, A. S.; Archer, S.; Bidlack, J. M. N-Cyclobutylmethyl Analog of Normorphinone, N-CBM-TAMO: A Short-Term Opioid Agonist and Long-Term Mu-Selective Irreversible Opioid Antagonist. J. Pharmacol. Exp. Ther. 1996, 279, 539-547. 12. Burke Jr, T. R.; Jacobson, A. E.; Rice, K. C.; Silverton, J. V.; Simonds, W. F. Probes for Narcotic Receptor Mediated Phenonmena. 12. Cis-(+)-3-Methylfentanyl Isothiocyanate, a Potent Site-Directed Acylating Agent for Opioid Receptors. Synthesis, Absolute Configuration, and Receptor Enantioselectivity. J. Med. Chem. 1986, 29, 1087-1093. 13. Zhu, J.; Yin, J.; Law, P. Y.; Claude, P. A.; Rice, K. C.; Evans, C. J.; Chen, C.; Yu, L.; Liu-Chen, L. Y. Irreversible Binding of Cis-(+)-3-Methylfentanyl Isothiocyanate to the Opioid Receptor and Determination of Its Binding Domain. J. Biol. Chem. 1996, 271, 1430-1434. 14. de Costa, B. R.; Band, L.; Rothman, R. B.; Jacobson, A. E.; Bykov, V.; Pert, A.; Rice, K. C. Synthesis of an Affinity Ligand (UPHIT) for in vivo Acylation of the -Opioid Receptor. FEBS. Lett. 1989, 249, 178-182. 15. De Costa, B. R.; Rothman, R. B.; Bykov, V.; Band, L.; Pert, A.; Jacobson, A. E. Probes for Narcotic Receptor Mediated Phenonmena. 17. Synthesis and Evaluation of a Series of trans-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide (U50,488) Related Isothiocyanate Derivatives as Opioid Receptor Affinity Ligands. J. Med. Chem. 1990, 33, 1171-1176. 16. Cheng, C. Y.; Wu, S. C.; Hsin, L. W.; Tam, S. W. Selective Reversible and Irreversible Ligands for the Opioid Receptor. J. Med. Chem. 1992, 35, 2243-2247. 17. Chang, A. C.; Takemori, A. E.; Ojala, W. H.; Gleason, W> B.; Portoghese, P. S. Opioid Receptor Selective Affinity Lables : Electrophilic Benzeneacetamides as -Selective Opioid Antagonist. J. Med. Chem. 1994, 37, 4490-4498. 18. Chen, C.; Yin, J.; Li, J. G.; Xue, J. C.; Weerawarna, S. A.; Nelson, W. L.; Liu-Chen, L. Y. Irreversible Binding of N-methyl-N-[(1S)-1-(4-Isothiocyanatophenyl)-2-(1-Pyrrolidinyl)Ethyl-3,4-Dichlorophenylacetamide to The Cloned Rat κ Opioid Receptor. Life Science, 1997, 61, 787-794. 19. Costello, G. F.; James, R.; Shaw, J. S.; Slater, A. M.; Stutchbury, N. C. J.2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-substituted-ethyl]-acetamides: The Use of Conformational Analysis in the Development of a Novel Series of Potent Opioid κ Agonists. J. Med. Chem. 1991, 34, 181-189. 20. Omura, K.; Swern, D. Tetrahedron, 1978, 34, 1651. 21. Corey, E. J.; Suggs, J. W. Pyridinium Chlorochromate. An Efficient Reagent for Oxidation of Primary and Secondary Alcohols to Carbonyl compounds. Tetrahedron Lett. 1975, 31, 2647. 22. Griffith, W. P.; Ley, S. V.; Whitcombe, G. P.; White, A. D. Preparation and Use of Tetra-n-butylammonium Per-ruthenate (TBAP reagent) and Tetra-n-propylammonium Per-ruthenate (TPAP reagent) as New Catalytic Oxidants for Alcohols. J. Chem. Soc., Chem. Commun. 1987, 1625-1627. 23. Ley, S. V.; Norman, J.; Griffith, W. P.; Marsden, S. P. Tetrapropylammonium Perruthenate, Pr4N+RuO4-, TPAP: A Catalytic Oxidant for Organic Synthesis. Synthesis, 1994, 639-666. 24. McDermott, J. R.; Benotion, N. L. N-Methylamino Acids in Peptide Synthesis. II. A New Synthesis of N-Benzyloxycarbonyl, N-Methylamino Acid. Can. J. Chem. 1973, 51, 1915-1919. 25. Cheung, S. T.; Benoiton, N. L. N-Methylamino acids in peptide synthesis. V. The Synthesis of N-tert-butyloxycarbonyl, N-methylamino acids by N-methylation. Can. J. Chem. 1977, 55, 906-910. 26. Maligres, P.E. et. al. Synthesis of the Orally Active Spiroindoline-Based Growth Hormone Secretagogue, MK-677. Tetrahedron, 1997, 53, 10983-10992. 27. Szantay, C.; Toke, L.; Kolonit, P. Synthesis of Protoemetine. A New Total Synthesis of Emetine. J. Org. Chem. 1966, 1447-1451. 28. Bare, T. M.; House, H. O. Methyl Ketones From Carboxylic Acids: Cyclohexyl Methyl Ketone. Org. Syn. 1969, 49, 81-85.
|